Late-Stage COVID-19 Vaccine Candidates Prepare for Authorizations

The U.S. FDA has not approved any preventive or therapeutic vaccines for use against the newly identified SARS-CoV-2 coronavirus. There are various vaccine candidates in development such as nucleic acid, virus-like particle, peptide, viral vector, recombinant protein, live attenuated virus, and inactivated virus approaches. The goal of these vaccines is to prevent SARS-CoV-2 from getting into cells, replicating itself, which then creates COVID-19, says the FDA.

An updated list of late-stage COVID-19 vaccine candidates as of October 17, 2020, is published in on this CoronavirusToday webpage.